4586 Medrx
- 127
- +30+30.93%
Medrx News
Medrx: Announcements of individual stocks regarding the decision to provide indirect subsidies for the overseas application support business subsidy program for SMEs and others in overseas expansion support project expenses for fiscal 2024.
Medrx: Regarding the policy towards reapplying for MRX-5LBT
Medrx: Announcement of revised financial estimates.
Medrx: Announcements of individual stocks: Notification of completion report received for MRX-5LBT review.
Medrx: Change report.
Medrx: Change report.
Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.
Medrx: Announcements of individual stocks regarding the monthly exercise status of the 29th subscription rights (with exercise price adjustment clause) issued through a third-party allocation.
Medrx: Announcements of individual stocks: Notice of the start of the Alto-101 Phase II clinical trial.
Medrx: Correction Report (Mass Ownership Report/Change Report)
Medrx: Change Report
Medrx: Announcement regarding the determination of the issuance content of the subscription rights (stock options) for solicitation.
Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
MEDRX: Change Report
MEDRX: Change Report
MEDRX: Extraordinary Report
MEDRX: Notice Concerning Issuance of Stock Acquisition Rights (Stock Acquisition Rights with Performance-Linked Conditions and Market Capitalization Conditions) and Stock Acquisition Rights (Stock Options)
MEDRX: Change Report
MEDRX: Notice regarding mass exercise, completion of exercise, and monthly exercise status of the 28th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment
MEDRX: Change Report
Analysis
Price Target
No Data
